1. Home
  2. IOVA vs GLDD Comparison

IOVA vs GLDD Comparison

Compare IOVA & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • GLDD
  • Stock Information
  • Founded
  • IOVA 2007
  • GLDD 1890
  • Country
  • IOVA United States
  • GLDD United States
  • Employees
  • IOVA N/A
  • GLDD N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • GLDD Military/Government/Technical
  • Sector
  • IOVA Health Care
  • GLDD Industrials
  • Exchange
  • IOVA Nasdaq
  • GLDD Nasdaq
  • Market Cap
  • IOVA 975.1M
  • GLDD 813.2M
  • IPO Year
  • IOVA N/A
  • GLDD 2006
  • Fundamental
  • Price
  • IOVA $1.83
  • GLDD $12.87
  • Analyst Decision
  • IOVA Buy
  • GLDD
  • Analyst Count
  • IOVA 11
  • GLDD 0
  • Target Price
  • IOVA $10.80
  • GLDD N/A
  • AVG Volume (30 Days)
  • IOVA 14.8M
  • GLDD 398.0K
  • Earning Date
  • IOVA 11-06-2025
  • GLDD 11-04-2025
  • Dividend Yield
  • IOVA N/A
  • GLDD N/A
  • EPS Growth
  • IOVA N/A
  • GLDD 36.27
  • EPS
  • IOVA N/A
  • GLDD 1.19
  • Revenue
  • IOVA $241,525,000.00
  • GLDD $834,599,000.00
  • Revenue This Year
  • IOVA $68.14
  • GLDD $13.73
  • Revenue Next Year
  • IOVA $56.64
  • GLDD $3.56
  • P/E Ratio
  • IOVA N/A
  • GLDD $10.74
  • Revenue Growth
  • IOVA 636.99
  • GLDD 12.53
  • 52 Week Low
  • IOVA $1.64
  • GLDD $7.51
  • 52 Week High
  • IOVA $12.51
  • GLDD $12.90
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 34.71
  • GLDD 69.98
  • Support Level
  • IOVA $1.94
  • GLDD $11.14
  • Resistance Level
  • IOVA $2.20
  • GLDD $11.69
  • Average True Range (ATR)
  • IOVA 0.14
  • GLDD 0.41
  • MACD
  • IOVA -0.04
  • GLDD 0.14
  • Stochastic Oscillator
  • IOVA 3.31
  • GLDD 93.47

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

Share on Social Networks: